home / stock / ambs / ambs news

AMBS News and Press, Amarantus BioScience Holdings Inc

Stock Information
Company Name: Amarantus BioScience Holdings Inc
Stock Symbol: AMBS
Market: OTC
Website: amarantus.com
Menu
AMBS AMBS Quote AMBS Short AMBS News AMBS Articles AMBS Message Board
Get AMBS Alerts

News, Short Squeeze, Breakout and More Instantly...
AMBS - Amarantus Signs Non-Binding Term Sheet to Divest Cutanogen Corporation in Exchange for the Extinguishment of Potential $21M+ in Liabilities

Board Member/Acting CEO Provides Shareholder Update Sale of Engineered Skin Substitute (ESS) subsidiary, Cutanogen Corporation. Emphasis placed on advancing Elto Pharma, Inc. and MANF Therapeutics programs NEW YORK, NY / ACCESSWIRE / April 27, 2022 / Amarantus Bioscience Hol...
AMBS - Todos Medical CEO Releases Letter to Shareholders

  Significant progress in establishing COVID-19 PCR-based diagnostic testing business in US 3CL Protease-based saliva test making progress in Israel 3CL Protease inhibitor NLC-001 dietary supplement added to commercial portfolio 2019 convertible note holders and instituti...

AMBS - 3CL Protease Inhibitor NLC-001 Added to COVID-19-focused Joint Venture Between Todos Medical and NLC Pharma

  NLC-001 is a proprietary blend of plant extracts administered orally as dietary supplement   US FDA granted Certificate of Free Sale for NLC-001 on August 28, 2020   JV evaluating potential of NLC-001 to treat COVID-19 in clinical studies in Israel   Todos e...

AMBS - Todos Medical Expands Partnership with Care G.B. Plus for Proprietary TBIA Cancer Tests to Include Europe, Israel and Africa

NEW YORK, REHOVOT, Israel and SINGAPORE, Sept. 16, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Todos Medical Ltd. (OTCQB: TOMDF) , an  in vitro  diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests f...
AMBS - Todos Medical Announces August Sales of $1,190,000, Up 100% Compared with July

NEW YORK, REHOVOT, Israel and SINGAPORE, Sept. 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Todos Medical Ltd. (OTCQB: TOMDF) , an  in vitro  diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests f...

AMBS - Todos Medical Announces $23,760,000 Contract for COVID-19 PCR Testing Equipment & Supplies With Wisconsin-based Laboratory

NEW YORK, NY, REHOVOT, Israel, and SINGAPORE, Aug. 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Todos Medical Ltd. (OTCQB: TOMDF) , an  in vitro  diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tes...

AMBS - Todos Medical Appoints Marsha Fontanive as VP of Sales and Chris Gross as VP of Sales Operations

NEW YORK, NY, REHOVOT, Israel, and SINGAPORE, Aug. 25, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Todos Medical Ltd. (OTCQB: TOMDF) , an  in vitro  diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood...
AMBS - Todos Medical Announces $1.2 Million Contract for COVID-19 PCR Testing Equipment & Supplies with Texas-based Laboratory

NEW YORK, NY, REHOVOT, Israel, and SINGAPORE, Aug. 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Todos Medical Ltd. (OTCQB: TOMDF) , an  in vitro  diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tes...

AMBS - Todos Medical Announces $6,000,000 Contract for COVID-19 PCR Testing Equipment & Supplies with New York-based Laboratory

  6-month contract anticipates demand of 3,000 tests per day   Todos has the right to supply up to 30,000 tests per day if demand increases for the lab NEW YORK, NY, REHOVOT, Israel, and SINGAPORE, Aug. 21, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Todos Medical Ltd. (O...

AMBS - Todos Medical Announces Positive Proof-of-Concept Data for Novel 10-Minute Point-of-Care Saliva-based Test Detecting Active SARS-CoV-2 Infection

  Achieves analytical performance for detecting active 3C-protease in a rapid visual format   Initiates multicenter clinical trial at Assuta Ashdod Hospital and Tel Aviv University in Israel   Technology opens potential for self-administered tests at home, school, wo...
Next 10